Form 4 for VERA Vera Therapeutics, Inc.
Accepted 2024-01-18 00:00:00 ET · period of report 2024-01-16 · accession 0001415889-24-001514 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-18 | 2024-01-16 | VERA | Grant Sean | CFO | A - Grant | $0.00 | +26.2K | 78.7K | +50% | $0 |
| D | 2024-01-18 | 2024-01-16 | VERA | Grant Sean | CFO | A - Grant | $0.00 | +97.5K | 97.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-01-16 | A | A | 26,250 | $0.00 | 78,683 | D | — | — | (F1) Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") under the Issuer's 2021 Equity Incentive Plan. One-fourth of the RSUs vest, rounded to the nearest whole share, on each of February 20, 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service through each vesting date. (F2) Includes 2,500 shares of Class A Common Stock acquired under the Issuer's 2021 Employee Stock Purchase Plan on September 13, 2023. |
| 2 | Derivative | Stock Option (right to buy) | 2024-01-16 | A | A | 97,500 | $0.00 | 97,500 | D | $16.80 · — to 2034-01-15 | 97,500 Class A Common Stock | (F3) 1/48 of the shares subject to the stock option will vest and become exercisable on February 16, 2024, and 1/48th of the shares subject to the stock option will vest and become exercisable monthly on the same day of each month thereafter, subject to the Reporting Person's continuous service through each vesting date. |